The Patent Trial and Appeal Board will not recognize Indian tribal sovereign immunity in inter partes review proceedings.

A three-judge panel of the board on Friday turned away the Saint Regis Mohawk Tribe’s bid to use sovereign immunity to shield Allergan Inc. from an administrative challenge to patent validity.